More than 20 years have passed since the last case of smallpoxwas confirmed and 18 years since the International Commissionfor the Certification of Smallpox Eradication of the World HealthOrganization (WHO) concluded that the global eradication ofsmallpox had been achieved.1,2 Now, new dilemmas confront theworld. Could recent outbreaks of human monkeypox in the DemocraticRepublic of the Congo (known as Zaire from 1971 to 1997)3,4,5represent the return of another form of smallpox?6 Could variola(smallpox) virus be used as a weapon of biologic terrorism?And what are the implications of the decision of the WHO . . . [Full Text of this Article]
Monkeypox in Humans
Smallpox as a Biologic Weapon
Destruction of Variola Virus
Conclusions
References
Related Letters:
Poxvirus Dilemmas
Hooper C., Breman J. G., Henderson D.A.
Extract |
Full Text
N Engl J Med 1998;
339:2027-2028, Dec 31, 1998.
Correspondence
This article has been cited by other articles:
Quenelle, D. C., Collins, D. J., Kern, E. R.
(2003). Efficacy of Multiple- or Single-Dose Cidofovir against Vaccinia and Cowpox Virus Infections in Mice. Antimicrob. Agents Chemother.
47: 3275-3280
[Abstract][Full Text]
Keith, K. A., Hitchcock, M. J. M., Lee, W. A., Holy, A., Kern, E. R.
(2003). Evaluation of Nucleoside Phosphonates and Their Analogs and Prodrugs for Inhibition of Orthopoxvirus Replication. Antimicrob. Agents Chemother.
47: 2193-2198
[Abstract][Full Text]
Snoeck, R., Holy, A., Dewolf-Peeters, C., Van Den Oord, J., De Clercq, E., Andrei, G.
(2002). Antivaccinia Activities of Acyclic Nucleoside Phosphonate Derivatives in Epithelial Cells and Organotypic Cultures. Antimicrob. Agents Chemother.
46: 3356-3361
[Abstract][Full Text]
Neyts, J., Verbeken, E., De Clercq, E.
(2002). Effect of 5-Iodo-2'-Deoxyuridine on Vaccinia Virus (Orthopoxvirus) Infections in Mice. Antimicrob. Agents Chemother.
46: 2842-2847
[Abstract][Full Text]
Espy, M. J., Cockerill III, F. R., Meyer, R. F., Bowen, M. D., Poland, G. A., Hadfield, T. L., Smith, T. F.
(2002). Detection of Smallpox Virus DNA by LightCycler PCR. J. Clin. Microbiol.
40: 1985-1988
[Abstract][Full Text]
Smee, D. F., Sidwell, R. W., Kefauver, D., Bray, M., Huggins, J. W.
(2002). Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia Viruses. Antimicrob. Agents Chemother.
46: 1329-1335
[Abstract][Full Text]
Ramirez, J. C., Tapia, E., Esteban, M.
(2002). Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions. J. Gen. Virol.
83: 1059-1067
[Abstract][Full Text]
Kern, E. R., Hartline, C., Harden, E., Keith, K., Rodriguez, N., Beadle, J. R., Hostetler, K. Y.
(2002). Enhanced Inhibition of Orthopoxvirus Replication In Vitro by Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir. Antimicrob. Agents Chemother.
46: 991-995
[Abstract][Full Text]
Khan, A. S., Ashford, D. A.
(2001). Ready or Not -- Preparedness for Bioterrorism. NEJM
345: 287-289
[Full Text]
Klietmann, W. F., Ruoff, K. L.
(2001). Bioterrorism: Implications for the Clinical Microbiologist. Clin. Microbiol. Rev.
14: 364-381
[Abstract][Full Text]
De Clercq, E.
(2001). Vaccinia Virus Inhibitors as a Paradigm for the Chemotherapy of Poxvirus Infections. Clin. Microbiol. Rev.
14: 382-397
[Abstract][Full Text]
Neyts, J., De Clercq, E.
(2001). Efficacy of 2-Amino-7-(1,3-Dihydroxy-2-Propoxymethyl)Purine for Treatment of Vaccinia Virus (Orthopoxvirus) Infections in Mice. Antimicrob. Agents Chemother.
45: 84-87
[Abstract][Full Text]
Henderson, D. A., Inglesby, T. V., Bartlett, J. G., Ascher, M. S., Eitzen, E., Jahrling, P. B., Hauer, J., Layton, M., McDade, J., Osterholm, M. T., O'Toole, T., Parker, G., Perl, T., Russell, P. K., Tonat, K., for the Working Group on Civilian Biodefense,
(1999). Smallpox as a Biological Weapon: Medical and Public Health Management. JAMA
281: 2127-2137
[Abstract][Full Text]
Previous
